The influx of FFAs contributes to insulin resistance, enhanced hepatic glucose production, impaired insulin degradation, and subsequent hyperinsulinemia, which collectively promote triglyceride synthesis, hepatic steatosis, and the development of non‐alcoholic fatty liver disease (NAFLD). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.